Scientific work

Uzm. Dr. Demet Polat Yuluğ

59 publications. The source of the information is stated next to each publication.

Back to profile

  1. Determination of the yearly distribution of the incidence of Allergic Bronchopulmonary Aspergillosis (ABPA) in patients registered in the cystic fibrosis patient registry system of Turkey and identification of risk factors for its development

    Chronic Illness, 2026

    DOI 10.1177/17423953261452631 PMID 42216671 Open-access full textSource: OpenAlex

  2. Impact of CFTR modulators on respiratory support requirements and lung transplant candidacy status in advanced cystic fibrosis lung disease: data from the cystic fibrosis registry of Turkey

    Journal of Cystic Fibrosis, 2026

    DOI 10.1016/s1569-1993(26)00552-7 Source: OpenAlex

  3. Multidrug-Resistant and Difficult-to-Treat Pseudomonas aeruginosa in Cystic Fibrosis: A Nationwide Registry Analysis from Türkiye

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa3943 Source: OpenAlex

  4. An analysis of cystic fibrosis transmembrane conductance regulator gene variants in the Cystic Fibrosis Registry of Türkiye

    European Journal of Pediatrics, 2026

    DOI 10.1007/s00431-026-07498-x PMID 42963477 Source: OpenAlex

  5. Validation and Reliability Assessment of the Test of Adherence to Inhalers (TAI) in Turkish Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Thoracic research and practice, 2026

    DOI 10.4274/thoracrespract.2026.2026-1-5 PMID 41979103 Open-access full textSource: OpenAlex

  6. Inhaler-specific drug therapy problems in COPD

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa2577 Source: OpenAlex

  7. Polypharmacy in COPD and Its Impact on Clinical Outcomes

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa5825 Source: OpenAlex

  8. Frailty, organ dysfunction and mortality in older ICU patients

    Scientific Reports, 2026

    DOI 10.1038/s41598-026-68534-2 Open-access full textSource: ORCID

  9. Predicting weaning failure in critically ill older patients: secondary analysis of a national multicenter prospective cohort in Türkiye

    BMC Geriatrics, 2026

    DOI 10.1186/s12877-026-07545-0 PMID 42026487 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  10. The Evaluation of the Genotype and Phenotype Relationship in Patients With Nasal Polyps in Cystic Fibrosis Registry of Turkey

    Pediatric Pulmonology, 2026

    DOI 10.1002/ppul.71608 PMID 41940472 Open-access full textSource: OpenAlex

  11. The Role of Genetic Testing in Rare Interstitial Lung Diseases: TRILD Registry Results

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa3087 Source: OpenAlex

  12. Methylprednisolone in the management of post-COVID-19 interstitial lung disease: A randomized trial (STERCOV-ILD).

    Sarcoidosis vasculitis and diffuse lung diseases, 2026

    DOI 10.36141/svdld.2026.17022 PMID 41891406 Open-access full textSource: OpenAlex

  13. Clinical and Radiological Characteristics of Patients with Lophomonas blattarum Detected in Bronchial Lavage: A Single-Center Experience

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2026

    DOI 10.1007/s10096-026-05539-9 PMID 42149374 Open-access full textSource: Europe PMC

  14. Small Airway Dysfunction in Asthma: Associations with Control and Quality of Life

    Thoracic research and practice, 2026

    DOI 10.4274/thoracrespract.2026.2026-1-7 PMID 42840719 Open-access full textSource: Europe PMC

  15. Tüberküloz Dışı Mikobakteri Enfeksiyonlarının Klinik Özellikleri ve Yıllık Olgu Sayılarının Zamansal Değişimi: Tek Merkezli Retrospektif Çalışma

    Journal of İzmir Chest Hospital, 2026

    DOI 10.14744/igh.2025.92400 Open-access full textSource: OpenAlex

  16. Longitudinal clinical outcomes of N1303K cystic fibrosis patients in the era of CFTR modulators

    Journal of Cystic Fibrosis, 2026

    DOI 10.1016/s1569-1993(26)01262-2 Source: OpenAlex

  17. Determinants of acute pulmonary exacerbations in cystic fibrosis: a nationwide registry-based analysis

    Journal of Cystic Fibrosis, 2026

    DOI 10.1016/s1569-1993(26)00544-8 Source: OpenAlex

  18. Clinical and Medicolegal Evaluation of Inhalation Injury Cases in the Forensic Process

    Turkish Journal of Forensic Medicine, 2026

    DOI 10.61970/adlitip.1938185 Open-access full textSource: OpenAlex

  19. Clinical and Prognostic Significance of Hemoptysis in Pulmonary Thromboembolism: Real-World Data from 400 Patients

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa6349 Source: OpenAlex

  20. Radiological spectrum in bronchopulmonary Lophomonas blattarum infection: Analysis of 69 cases

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa4294 Source: OpenAlex

  21. Association Between E-Cigarette Knowledge Level, Attitudes, and Clinical Approach Among Resident Physicians

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa1695 Source: OpenAlex

  22. Real-world effectiveness of cytisine for smoking cessation: A retrospective single-center study

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa6020 Source: OpenAlex

  23. Serum Alpha1 Antitrypsin Level and Alpha1 Gene Mutation Frequency in Patients with Chronic Obstructive Pulmonary Disease in Mersin Province

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa3811 Source: OpenAlex

  24. Impact of Modulator Therapy on the Chronic Colonization of Lower Respiratory Tract Pathogens in Children: Data From Cystic Fibrosis Registry of Turkey

    Pediatric Pulmonology, 2025

    DOI 10.1002/ppul.71155 PMID 40504038 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  25. P226 Impact of modulator therapy on the chronic colonization of lower respiratory tract pathogens in children: data from the cystic fibrosis registry of Turkey

    Journal of Cystic Fibrosis, 2025

    DOI 10.1016/j.jcf.2025.03.1112 Source: OpenAlex

  26. P169 Allergic bronchopulmonary aspergillosis in Turkey - the incidence and identification of risk factors for its development

    Journal of Cystic Fibrosis, 2025

    DOI 10.1016/j.jcf.2025.03.1055 Source: OpenAlex

  27. P384 Evaluation of rare cystic fibrosis transmembrane conductance regulator gene variants according to seven functional classes from Turkish National Cystic Fibrosis Patient Registry

    Journal of Cystic Fibrosis, 2025

    DOI 10.1016/j.jcf.2025.03.1268 Source: OpenAlex

  28. Comparison of newborn screening and modulatory treatment responses in siblings with cystic fibrosis

    European Respiratory Journal, 2025

    DOI 10.1183/13993003.congress-2025.pa1625 Source: OpenAlex

  29. Impact of COVID-19 and lockdown on outcomes of COPD patients in Turkey: lessons for the future

    BMC Pulmonary Medicine, 2025

    DOI 10.1186/s12890-025-03883-8 PMID 40885974 Open-access full textSource: OpenAlex

  30. Inhaler Technique and Medication Adherence in COPD: Insights from a Nationwide Multicentre Study

    Research Square, 2025

    DOI 10.21203/rs.3.rs-8302012/v1 Open-access full textSource: OpenAlex

  31. Factors influencing the prescription of add-on long-acting muscarinic antagonists in real-world asthma management: Insights from a national registry

    Respiratory Medicine, 2025

    DOI 10.1016/j.rmed.2024.107883 PMID 39617354 2 citations (Europe PMC) Source: ORCID

  32. Asthma patients with obesity have a unique phenotype: a subanalysis of the Turkish adult asthma registry

    The Journal of asthma : official journal of the Association for the Care of Asthma, 2025

    DOI 10.1080/02770903.2025.2466182 PMID 39932533 4 citations (Europe PMC) Source: Europe PMC

  33. Distinct characteristics of asthma overlap phenotypes: Insights from the Turkish adult asthma registry

    The Journal of asthma : official journal of the Association for the Care of Asthma, 2025

    DOI 10.1080/02770903.2025.2493134 PMID 40238182 Source: Europe PMC

  34. Socioeconomic status has direct impact on asthma control: Turkish adult asthma registry

    Clinical and Translational Allergy, 2025

    DOI 10.1002/clt2.70018 PMID 39865387 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  35. Trends in prescribing montelukast in patients with asthma in real-life: Results from the Turkish adult asthma registry

    Allergologia et Immunopathologia, 2025

    DOI 10.15586/aei.v53i1.1183 PMID 39786871 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  36. Identifying future risk factors of uncontrolled asthma control: the TAAR study perspective

    Journal of Asthma, 2025

    DOI 10.1080/02770903.2025.2592244 PMID 41305966 1 citation (OpenAlex) Source: OpenAlex

  37. What Does Radiologic Assessment Contribute to Asthma: A Subanalysis of the Turkish Adult Asthma Registry

    Bratislavské lekárske listy/Bratislava medical journal, 2025

    DOI 10.1007/s44411-025-00104-w Open-access full textSource: OpenAlex

  38. P010 The evaluation of the genotype and phenotype relationship in patients with nasal polyps in the National Cystic Fibrosis Registry

    Journal of Cystic Fibrosis, 2025

    DOI 10.1016/j.jcf.2025.03.029 Source: OpenAlex

  39. Unusual Presentation of Cryptogenic Organizing Pneumonia with Multiple Pulmonary Nodules Resembling Pulmonary Metastases: A Case Report

    Respiratory Case Reports, 2025

    DOI 10.5505/respircase.2025.54289 Open-access full textSource: OpenAlex

  40. Impact of Cold Spells on Community-Acquired Pneumonia Incidence

    Research Square, 2025

    DOI 10.21203/rs.3.rs-7515402/v1 Open-access full textSource: OpenAlex

  41. Antifibrotic treatment in idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF):similarities and differences

    European Respiratory Journal, 2025

    DOI 10.1183/13993003.congress-2025.pa1836 Source: OpenAlex

  42. The presence of coronary artery calcification on computed tomography and its impact on early outcomes in patients with pulmonary thromboembolism

    European Respiratory Journal, 2025

    DOI 10.1183/13993003.congress-2025.oa5494 Source: OpenAlex

  43. Antifibrotic Treatment in Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF): Real-World outcomes from a Single-Center study

    Lung India, 2025

    DOI 10.4103/lungindia.lungindia_141_25 PMID 41474422 Open-access full textSource: OpenAlex

  44. FAMILIAL INTERSTITIAL PNEUMONIAS (SP-C/TELOMERE SHORTENING/ABCA3)

    Turkiye Klinikleri eBooks, 2025

    DOI 10.5336/978-625-395-726-1_p135 Source: OpenAlex

  45. P001 Evaluation of the relationship between quantitative levels of immunereactive trypsinogen & sweat chloride levels, genetic mutations, and pancreatic involvement in cystic fibrosis patients

    Journal of Cystic Fibrosis, 2024

    DOI 10.1016/s1569-1993(24)00309-6 Open-access full textSource: OpenAlex

  46. Rate of critical errors in inhaler device use in COPD and associated factors with poor inhaler technique: a multicenter study

    European Respiratory Journal, 2024

    DOI 10.1183/13993003.congress-2024.pa2127 Source: OpenAlex

  47. Economic burden of short-acting beta-2 agonist (SABA) overuse among asthma patients in Türkiye: a cost analysis with respect to the updated GINA treatment recommendations

    BMC Pulmonary Medicine, 2024

    DOI 10.1186/s12890-024-03327-9 PMID 39434065 2 citations (OpenAlex) Open-access full textSource: ORCID

  48. Post-COVID Interstitial Lung Disease: How do We Deal with This New Entity?

    Balkan medical journal, 2024

    DOI 10.4274/balkanmedj.galenos.2024.2024-3-82 PMID 39192585 5 citations (Europe PMC) Open-access full textSource: Europe PMC

  49. Physicians’ irrational attitudes on the antibiotic prescribing for the treatment of COVID-19 in Turkey: A multicenter survey

    BMC Health Services Research, 2024

    DOI 10.1186/s12913-024-11110-z PMID 38773553 5 citations (OpenAlex) Open-access full textSource: OpenAlex

  50. Picturing asthma in Turkey: results from the Turkish adult asthma registry

    Journal of Asthma, 2023

    DOI 10.1080/02770903.2023.2206902 PMID 37096963 17 citations (Europe PMC) Source: ORCID